These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18377844)

  • 1. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Bepler G; Chang A; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Feigenberg SJ; Figlin RA; Govindan R; Grannis FW; Jahan T; Jahanzeb M; Kessinger A; Komaki R; Kris MG; Langer CJ; Le QT; Martins R; Otterson GA; Patel JD; Robert F; Sugarbaker DJ; Wood DE
    J Natl Compr Canc Netw; 2008 Mar; 6(3):228-69. PubMed ID: 18377844
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.
    Thomas PA
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):431-2. PubMed ID: 19524447
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-small cell lung cancer].
    Yoshimura A; Niitani H
    Ryoikibetsu Shokogun Shirizu; 1994; (4):100-3. PubMed ID: 8007089
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of non-small cell lung cancer].
    Solignac M
    Presse Med; 2000 Jul; 29(23):1328-31. PubMed ID: 10923144
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer.
    Rusch VW
    Ann Thorac Surg; 1994 Sep; 58(3):899-900. PubMed ID: 7944732
    [No Abstract]   [Full Text] [Related]  

  • 6. [Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy].
    Fournel P
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S8-15. PubMed ID: 15211226
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer.
    D'Angelillo RM; Trodella L; Ramella S
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):489-90. PubMed ID: 15354115
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal treatment of unresectable stage III non-small cell lung cancer.
    Bradley JD
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):853-855. PubMed ID: 27930635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of stage III non-small lung carcinomas: is there controversy?].
    Mornex F; Girard N
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S20-3. PubMed ID: 17404534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of unresectable stage III non-small-cell lung carcinomas].
    Van Houtte P
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S24-6. PubMed ID: 17404535
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approach.
    Stupp R; Betticher D; Ris HB; Peters S; Pless M
    J Clin Oncol; 2011 Feb; 29(5):e118-9; author reply e120. PubMed ID: 21205753
    [No Abstract]   [Full Text] [Related]  

  • 12. Stage II (T3) lung cancer.
    Allen MS; Jett JR; Kozelsky TF
    Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced non-small-cell lung cancer: new effective therapeutic alternatives for tomorrow?].
    Pérol M
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S20-7. PubMed ID: 15211228
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of "limited" stage III non-small cell carcinoma of the lung.
    Frytak S; Eagan RT; Sawamura K; Lee RE; Pairolero PC
    Cancer Invest; 1988; 6(2):193-207. PubMed ID: 2837315
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a standard treatment for locally advanced non-small cell lung cancer?
    Buccheri G
    Chest; 1996 Apr; 109(4):864-6. PubMed ID: 8635360
    [No Abstract]   [Full Text] [Related]  

  • 16. Locally advanced non-small cell lung cancer: different strategies for different diseases.
    Antonelli G; Priolo D; Vitale F; Ferraù F
    Ann Oncol; 2006 Mar; 17 Suppl 2():ii24-27. PubMed ID: 16608975
    [No Abstract]   [Full Text] [Related]  

  • 17. [To improve the survival rate of patients suffering from locally advanced non-small cell lung cancer with combination of radiotherapy and chemotherapy].
    Zhu GY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):88-90. PubMed ID: 17445466
    [No Abstract]   [Full Text] [Related]  

  • 18. Multimodality approach to management of stage III non-small cell lung cancer.
    Scarpaci A; Mitra P; Jarrar D; Masters GA
    Surg Oncol Clin N Am; 2013 Apr; 22(2):319-28. PubMed ID: 23453337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal therapy for elderly patients with early stage non-small cell lung cancer.
    Bunn PA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):201-2. PubMed ID: 20093653
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L; Robinson LA; Wagner H
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.